Our researchers and clinicians dedicate their careers to the prevention and treatment of cancer, and the care of patients. Their individual and collective quests for breakthroughs that will benefit society are the inspiration behind this collection of articles.
Drawn from our ‘Cancer Futures’ magazine, these features reflect Manchester’s breadth and depth of expertise from the laboratory to the bedside. They will give you a snapshot of our incredible cancer research activity and the people behind it.
You can also download the first edition of the Cancer Futures magazine (PDF, 15.2MB):
Professor Rob Bristow explains why getting cancer team research aligned will lead to better patient outcomes globally.
Professor Bristow explains what drew him to Manchester from his previous position in Toronto, Canada.
Professor Vaskar Saha’s research is helping to significantly reduce mortality rates in children being treated for cancer in India.
Professor Catharine West tells us how her decision to come to Manchester has enabled her to pioneer developments in personalised radiotherapy.
Professor Ananya Choudhury tells us how one of the world’s most innovative radiotherapy treatment machines will transform patient outcomes in 2019.
Go beyond the stories and find out more about Manchester’s cancer research.
Cancer research in Manchester takes place within a unique landscape where three world-leading organisations work hand in hand.
The potent expertise of Cancer Research UK, The Christie NHS Foundation Trust, and The University of Manchester comes together within the Manchester Cancer Research Centre (MCRC).
Discover more about cancer research at Manchester:
The UK’s first proton beam and research centre will be directed by Professor Karen Kirkby, who outlines how Manchester is pioneering ground-breaking proton beam research.
Andy Brass, Professor of Bioinformatics outlines the diversity of the data and expertise needed in cancer research, from computer science to medicine and genomics.
Professor Tim Illidge, Head of the Division of Cancer Sciences, is clear on what he thinks makes our research so successful.
Professor Caroline Dive CBE and her team, side by side with The Christie, are developing ‘liquid biopsies’ to hunt cancer cells that have broken free from tumours.
Professor Sir Salvador Moncada from The University of Manchester outlines why he considers the prevention and early detection of cancer the only way forward.
With a focus on ovarian cancer and drug development, Professor Gordon Jayson explains the benefits of Manchester's ability to run multiple novel clinical trials.
Professor Paul A. Townsend holds a unique position at the interface of both research and industry. In relation to cancer, discover what he believes the future holds for both sectors.
A mobile screening scheme pioneered in Manchester has helped to improve the early detection of lung cancer. Dr Philip Crosbie explains why Manchester the perfect place to trial the study.
Professor Andrew Renehan explains how his home-focused cancer research programme is benefitting the global population.